Aristolochic acid: A toxicological review

Clinical Acupuncture and Oriental Medicine

Volumn 1, Issue 3, 2000, Pages 161-166

  Pokhrel, Prabhat K ^a   Ergil, Kevin V ^b  

^a New York Coll Wholistic Hlth E   (United States)

^b TOURO COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0040185988     PISSN: 14611449     EISSN: None     Source Type: Journal    
DOI: 10.1054/caom.2000.0059     Document Type: Article

References (19)

1. Cosyns J, Goebbels R, Liberton V, Schmeiser H H, Bieler C A, Bernard A M. Chinese herbs nephropathy-associated slimming regimen induces tumors in the forestomach but no interstitial nephropathy in rats. Arch Toxicol. 72:1998;738-743.
2. Dharmananda S. The strange story of Stephania: Lessons about herb substitution, toxicity, and modern research. Start Group subscription series. 1997;Institute for Traditional Medicine, Portland. p. pp1-25.
3. Lord G M, Tagore R, Cook T, Gower P, Pusey C D. Nephropathy caused by Chinese herbs in the UK. Lancet. 354:1999;481-482.
4. McGuffin M, Hobbs C, Upton B, Goldber A. Botanical safety handbook. 1997;CRC Press, New York.
5. Mengs U, Lang W, Poch J A. The carcinogenic action of aristolochic acid in rats. Arch Toxicol. 51:1982;107-119.
6. Mengs U. On the histopathogenensis of rat forestomach carcinoma caused by aristolochic acid. Arch Toxicol. 52:1983;209-220.
7. Mengs U, Stotzem C D. Renal toxicity of aristolochic acid in rats as an example of nephrotoxicity testing in routine toxicology. Arch Toxicol. 67:1993;307-311.
8. Nishida R, Fukami H. Ecological adaptation of an Aristolochia-cceae feeding swallowtail butterfly, Atrophaneura alcinous, to aristolochic acids. J Chem Ecol. 15:1989;2549-2563.
9. Nortier J L, Martinez M M, Schmeiser H H, Arlt V M, Bieler C A, Petein M, Depierreux M F, Pauw L, Abramowicz D, Vereerstraeten P, Vanherweghem J. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). New Engl J Med. 342:2000;1686-1692.
10. Peters G, Hedwall P R. Aristolochic acid intoxication: a new type of impairment of urinary concentrating ability. Arch Int Pharmacodyn. 145:1963;334-355.
11. Pistelli L, Nieri E, Bilia A R, Marsili A. Chemical constituents of Aristolochia rigida and mutagenic activity of aristolochic acid IV. J Nat Prod. 56:1993;1605-1608.
12. Rao K V, Tanrikut Y, Killion K. Fluorometric and GLC analyses of aristolochic acid. J Pharm Sci. 64:1975;345-347.
13. Rosenkranz H S, Mermelstein R. Mutagenicity and genotoxicity of nitroarenes: all nitro-containing chemicals were not created equal. Mutat Res. 114:1983;217-267.
14. Schmeiser H H, Scherf H R, Weissler M. Activating mutations at codoen 61 of the c-Ha-ras gene in thin-tissue sections of tumors induced by aristolochic acid in rats and mice. Can Lett. 59:1991;139-143.
15. Stiborova M, Frei E, Breuer A, Bieler C A, Schmeiser H H. Aristolactam I a metabolite of aristolochic acid I upon activation forms an adduct found in DNA of patients with Chinese herbs nephropathy. Exp Toxicol Pathol. 51:1999;421-427.
16. Tanaka A, Nishida R, Maeda K, Sugawara A, Kuwahara T. Chinese herb nephropathy in Japan presents adult-onset Fanconi syndrome: could different components of aristolochic acids casue a different type of Chinese herb nephropathy? Clin Nephrol. 53:2000;301-306.
17. Vanherweghem J-L, Depierreux M, Tielemans C, Abramowicz D, Dratwa M, Jadoul M, Richard C, Vandervelde D, Verbeelen D, Vanhalen-Fastre R, Vanhalen M. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen inlcuding Chinese herbs. Lancet. 341:1993;387-391.
18. Vanhaelen M, Vanhaelen-Fastre R, But P, Vanherweghem L. Identification of aristolochic acid in Chinese herbs. Lancet. 343:1994;174.
19. Yang C, Lin C, Chang S, Hsu H. Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs. Am J Kid Dis. 35:2000;313-318.